Single‐center off‐label benralizumab use for refractory hypereosinophilic syndrome demonstrates satisfactory safety and efficacy
Authors
- Yvonne Veltman
- Anna M. Aalbers (ORCID: https://orcid.org/0009-0007-5375-7225)
- Pim G. N. J. Mutsaers (ORCID: https://orcid.org/0000-0002-3924-8578)
- Maud A.W. Hermans (ORCID: https://orcid.org/0000-0002-1643-8387)
Institutions
- Erasmus MC (NL)
Publication Details
- Journal
- eJHaem
- Published
- 2024-12-25
- DOI
- https://doi.org/10.1002/jha2.1014
- Citations
- 2
- Primary Topic
- Eosinophilic Disorders and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 0.94